Australian Diabetes Society

Australian Islet Study Group Meeting 2024
2024-05-15 00:00 - 2024-05-16 23:59 (Australia/Melbourne) | The Westmead Institute for Medical Research, 176 Hawkesbury Road, Westmead, NSW, 2145, Australia
The Australian Islet Study Group (AISG) Meeting is the premier meeting for researchers interested in all aspects of islet and beta cell function; including secretion pathway mechanisms, islet structure and function, morphology, in vitro and in vivo models, omics and big data considerations. We invite you to attend this exciting annual meeting discussing islet biology as it relates to clinical situations including diabetes and challenges in islet transplantation. The AISG Meeting 2024 will take place on Wednesday, 15th & Thursday, 16th May 2024 at The Westmead Institute for Medical Research in Westmead, NSW.
Click here for the program.
Click here to register for the event.
Full registration: A$190.00 (GST included)
Student registration: A$90.00 (GST included)

Speakers

Keynote Speaker
Professor Lori Sussel
Lori Sussel is the Research Director of the Barbara Davis Diabetes Center (BDC) and Director of the NIDDK-funded University of Colorado Diabetes Research Center. She received her graduate degree from Columbia University Medical School and pursued a postdoctoral fellowship at the University of California, San Francisco. Her research program involves two major areas of study. One aspect of her research is to understand the biology underlying pancreatic islet cell development and function. These studies have contributed to the ability to grow human islet cells in a dish for cell replacement therapy in type 1 diabetes (T1D). The second aspect of her research is to understand why the immune system targets the insulin producing beta cells within the pancreas with hopes that this knowledge will help prevent disease initiation or protect the beta cells after disease onset. As BDC Research Director, Professor Sussel has also established an internationally recognised interdisciplinary research division focusing on all aspects of T1D research and discovery.

Program

Click to view the program.

The ADS gratefully acknowledges the support from Lilly and Sanofi for this educational event.

Updates from European Renal Association (ERA) Congress 2024 – Outcomes and Clinical Implications of GLP-1 RA in T2DM and CKD
2024-05-27 19:00 - 20:00 | VIC
Live Panel Discussion
The use of GLP-1 agonists are revolutionising the care of type 2 diabetes and chronic kidney disease. Join us on Monday, 27 May 2024 from 7:00 pm to 8:00 pm (AEST) as our panel of experts discuss the effects of GLP-1 agonists on renal outcomes.
We will be reviewing study results presented at the ERA Congress 2024 and their implications for clinical practice in Australia.

Expert Panel

Click here to view the event flyer.
Click here to register for the webinar.
Registration is free to attend.
For any further information please contact the ADS Secretariat via email to ads@diabetessociety.com.au

The ADS gratefully acknowledges the support from Novo Nordisk. This is an independent educational event and Novo Nordisk does not have an influence on the program, speakers or presentations.
